Shortly after paying $800 million to take full control of BNT327, the biotech began a phase 3 trial to test the bispecific in combination with chemo in patients with previously untreated extensive ...

X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) is currently evaluating mavorixafor in a Phase 3 clinical trial in chronic neutropenia (CN) patients. The 4WARD trial is expected to enroll a total of 150 ...

There are no approved treatments for first-line aGVHD. The Phase 3, randomized, double-blind, placebo-controlled multicenter study (NCT05263999) compared the efficacy and safety of intravenous ...

The New York City central nervous system (CNS) specialist has scored in a phase 3 trial testing Sunosi (solriamfetol) on adults with attention deficit hyperactivity disorder (ADHD). The study ...

9 Nintendo Switch 2 Games It NEEDS to Have - Super Mario Odyssey 2 & More! Watch on YouTube The second phase of Nintendo's game launch plan is then reportedly set for around October-November ...